Abbvie Inc
NYSE: ABBV
$215.03
+$3.26 (+1.5%)
Real Time Data Delayed 15 Min.
ABBV Articles
GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews vast numbers of research reports looking for the best stocks to buy and...
Published:
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013. They include Apple, 3D Systems, Micron Technology and Tesla Motors.
Published:
Jon OggWe are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new all-time highs almost daily. So how do investors know which stocks to buy and which ones to sell?...
Published:
ThinkstockThe saying is that if there is a trading strategy, then there is an ETF strategy for that as well. Now the markets are getting a new exchange-traded fund strategy aimed at tracking the...
Published:
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown and impending debt ceiling weighed heavily on biotech stocks....
Published:
ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more radical efforts to increase their total return for shareholders. Some may go...
Published:
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
ThinkstockOne of the downsides to a market that seems to go up every day is knowing what stocks to own or sell as the market chugs higher. One strategy for investors to consider is keep a weighting...
Published:
ThinkstockAbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.68...
Published:
Last Updated:
U.S. equity markets opened higher this morning, but struggled to stay in positive territory for most of the morning. There was little economic data released today. In Asia, Hong Kong’s consumer...
Published:
Last Updated:
Investors and traders are on the lookout for fresh research ideas from Wall St. that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each and every...
Published:
Last Updated:
ThinkstockWith the markets making new highs seemingly every day, it is understandable that investors may be finding it harder and harder to find stocks that do not appear overvalued, or at a minimum...
Published:
U.S. equity markets opened flat this morning, largely due to a slew of data from Europe that essentially cancelled any good news with an equal dollop of bad. U.S. unemployment data came out before...
Published:
Last Updated:
ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research report issued today, Credit Suisse Group Inc. (NYSE: CS) issues some not very...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.